CoChat

Efficacy and Tolerability of Benzodiazepines versus Antidepressants in Anxiety Disorders: A Systematic Review and Meta-Analysis

Offidani, Emanuela, Guidi, Jenny, Tomba, Elena, Fava, Giovanni Andrea · 2013 · Psychotherapy and Psychosomatics

The DOI matches its Crossref record; 66 of the 66 references it cites were found in a registry or an index.

Abstract

Background: Placebo-controlled trials showed that both benzodiazepines (BDZ) and antidepressant drugs (AD) are effective in treating anxiety disorders. However, in the last years a progressive shift in the prescribing pattern from BDZ to newer AD has taken place. The aim of this systematic review and meta-analysis is to analyze whether controlled comparisons support such a shift. Methods: CINHAL, the Cochrane Library, MEDLINE, PubMed and Web of Science were searched from inception up to December 2012. A total of 22 studies met the criteria for inclusion. They were mostly concerned with tricyclic antidepressants (TCA; 18/22) and involved different anxiety disorders. In order to reduce clinical heterogeneity, only the 10 investigations that dealt with the comparison between TCA and BDZ in panic disorder were submitted to meta-analysis, whereas the remaining papers were individually summarized and critically examined. Results: According to the systematic review, no consistent evidence emerged supporting the advantage of using TCA over BDZ in treating generalized anxiety disorder (GAD), complex phobias and mixed anxiety-depressive disorders. Indeed, BDZ showed fewer treatment withdrawals and adverse events than AD. In panic disorder with and without agoraphobia our meta-analysis found BDZ treatments more effective in reducing the number of panic attacks than TCA (risk ratio, RR = 1.13; 95% CI = 1.01-1.27). Furthermore, BDZ medications were significantly better tolerated than TCA drugs, causing less discontinuation (RR = 0.40; 95% CI = 0.20-0.57) and side effects (RR = 0.41; 95% CI = 0.34-0.50). As to newer AD, BDZ trials resulted in comparable or greater improvements and fewer adverse events in patients suffering from GAD or panic disorder. Conclusions: The change in the prescribing pattern favoring newer AD over BDZ in the treatment of anxiety disorders has occurred without supporting evidence. Indeed, the role and usefulness of BDZ need to be reappraised.

Overview

Integrity signals

Registry

Crossref · 10.1159/000353198

Cites

66 of 66 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 66 references

Research works printed but not linked: 1

  1. 10.1159%2f000334112 · DOI

Cited by

See all 195

Metadata

Authors
Offidani, E., Guidi, J., Tomba, E., & Fava, G. A.
Affiliations
  • University of Bologna (IT)
  • University at Buffalo, State University of New York (US)
Venue
Psychotherapy and Psychosomatics
Publisher
S. Karger AG
Published
2013
Volume
82
Issue
6
Pages
355-362
ISSN
  • 0033-3190 (ISSN-L)
  • 1423-0348
OpenAlex
W2058854656
Cited by
166
References
64
Citations by year
2026: 2 · 2025: 10 · 2024: 17 · 2023: 8 · 2022: 12 · 2021: 6 · 2020: 17 · 2019: 12 · 2018: 16 · 2017: 17 · 2016: 13 · 2015: 16 · 2014: 17 · 2013: 2
FWCI
2.65
Type
journal article
Language
en
Open access
closed
Licence
Locations
  • Psychotherapy and Psychosomatics (publishedVersion)
  • PubMed (publishedVersion)
  • Archivio istituzionale della ricerca (Alma Mater Studiorum Università di Bologna) (submittedVersion)
Topics
  • Social Sciences › Psychology › Experimental and Cognitive Psychology › Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
  • Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
  • Health Sciences › Medicine › Psychiatry and Mental health › Mental Health Treatment and Access
Keywords
benzodiazepines, antidepressants, anxiety disorders, tricyclic antidepressants, panic disorder, generalized anxiety disorder, mixed anxiety-depressive disorder, treatment efficacy, tolerability, adverse events, treatment withdrawal, prescribing patterns
MeSH terms
Antidepressive Agents, Antidepressive Agents, Tricyclic, Anxiety Disorders, Benzodiazepines, Humans, Obsessive-Compulsive Disorder, Practice Patterns, Physicians', Randomized Controlled Trials as Topic, Treatment Outcome, Evidence-Based Medicine

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Efficacy and Tolerability of Benzodiazepines versus Antidepressants in Anxiety Disorders: A Systematic Review and Meta-Analysis. https://app.cochat.ai/papers/10.1159/000353198
The paper
Offidani, E., Guidi, J., Tomba, E., & Fava, G. A. (2013). Efficacy and Tolerability of Benzodiazepines versus Antidepressants in Anxiety Disorders: A Systematic Review and Meta-Analysis. Psychotherapy and Psychosomatics. https://doi.org/10.1159/000353198

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.